Zithromax: Advanced Azithromycin Therapy for Effective Bacterial Infection Resolution
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.44 | $34.40 (0%) | 🛒 Add to cart |
| 20 | $2.58 | $68.80 $51.60 (25%) | 🛒 Add to cart |
| 30 | $2.29 | $103.20 $68.80 (33%) | 🛒 Add to cart |
| 60 | $1.43 | $206.40 $86.00 (58%) | 🛒 Add to cart |
| 90 | $1.24 | $309.60 $111.80 (64%) | 🛒 Add to cart |
| 120 | $1.00 | $412.80 $120.40 (71%) | 🛒 Add to cart |
| 180 | $0.72 | $619.20 $129.00 (79%) | 🛒 Add to cart |
| 270 | $0.51 | $928.80 $137.60 (85%) | 🛒 Add to cart |
| 360 | $0.47
Best per pill | $1238.40 $167.70 (86%) | 🛒 Add to cart |
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.30 | $43.00 (0%) | 🛒 Add to cart |
| 20 | $3.01 | $86.00 $60.20 (30%) | 🛒 Add to cart |
| 30 | $2.58 | $129.00 $77.40 (40%) | 🛒 Add to cart |
| 60 | $2.01 | $258.00 $120.40 (53%) | 🛒 Add to cart |
| 90 | $1.91 | $387.00 $172.00 (56%) | 🛒 Add to cart |
| 120 | $1.72 | $516.00 $206.40 (60%) | 🛒 Add to cart |
| 180 | $1.29 | $774.00 $232.20 (70%) | 🛒 Add to cart |
| 270 | $1.05 | $1161.00 $283.80 (76%) | 🛒 Add to cart |
| 360 | $1.02
Best per pill | $1548.00 $365.50 (76%) | 🛒 Add to cart |
Zithromax (azithromycin) is a macrolide antibiotic renowned for its broad-spectrum efficacy and convenient dosing regimen. It is a cornerstone in modern antimicrobial therapy, designed to combat a wide array of susceptible bacterial pathogens. Its unique pharmacokinetic profile allows for shorter treatment courses and high tissue penetration, enhancing patient compliance and therapeutic outcomes. This product card provides a comprehensive, expert-level overview for healthcare professionals seeking detailed information on its appropriate clinical application.
Features
- Active ingredient: Azithromycin (as dihydrate)
- Available formulations: Oral tablets (250 mg, 500 mg, 600 mg), oral suspension (100 mg/5 mL, 200 mg/5 mL), and intravenous solution (500 mg vial)
- Mechanism of action: Binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis
- Spectrum: Effective against Gram-positive, Gram-negative, anaerobic, and atypical pathogens
- Pharmacokinetics: Extensive tissue distribution with prolonged half-life (~68 hours)
- Regulatory status: Prescription-only medication (Rx)
Benefits
- Rapid onset of action with significant symptomatic improvement often within 48–72 hours
- Convenient once-daily dosing regimen improves adherence and reduces treatment burden
- High bioavailability and excellent penetration into respiratory tissues, skin, and soft structures
- Short typical course duration (often 3–5 days) due to sustained post-antibiotic effect
- Well-established safety profile with extensive clinical use across diverse patient populations
- Effective against common community-acquired pathogens, including those with partial penicillin resistance
Common use
Zithromax is indicated for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms. Primary applications include community-acquired pneumonia, acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis, pharyngitis/tonsillitis, uncomplicated skin and skin structure infections, urethritis and cervicitis, and genital ulcer disease. It is also employed in the management of otitis media in pediatric patients and as part of combination therapy for Mycobacterium avium complex (MAC) prophylaxis in advanced HIV. Off-label uses may include certain gastrointestinal infections, Lyme disease prophylaxis, and pertussis treatment, though these require careful clinical judgment.
Dosage and direction
Dosage varies significantly based on infection type, severity, patient age, renal function, and formulation. For most adult respiratory and skin infections: 500 mg as a single dose on day 1, followed by 250 mg once daily on days 2 through 5 (total dose 1.5 g). For sexually transmitted infections: single 1 g oral dose. Pediatric dosing is weight-based, typically 10 mg/kg on day 1 (max 500 mg), then 5 mg/kg on days 2–5 (max 250 mg). Intravenous dosing is reserved for hospitalized patients with severe infections: 500 mg IV once daily for at least two days, followed by oral therapy to complete a 7–10 day course. Administer tablets with or without food; suspension should be taken on an empty stomach (1 hour before or 2 hours after meals). Complete the full prescribed course even if symptoms improve earlier.
Precautions
Use with caution in patients with hepatic impairment; consider monitoring liver function tests during prolonged therapy. May exacerbate muscle weakness in individuals with myasthenia gravis. There is a potential for prolonged cardiac repolarization (QT interval prolongation); avoid in patients with known QT prolongation, uncorrected hypokalemia or hypomagnesemia, or concomitant use of other QT-prolonging agents. Use in pregnancy only if clearly needed (Category B). Azithromycin is excreted in breast milk; weigh benefits against potential risks during lactation. Superinfection with Clostridioides difficile or fungi may occur; evaluate patients who develop diarrhea during or after treatment.
Contraindications
Hypersensitivity to azithromycin, erythromycin, or any other macrolide or ketolide antibiotic. Contraindicated in patients with a history of cholestatic jaundice or hepatic dysfunction associated with prior azithromycin use. Should not be administered concurrently with ergot derivatives or drugs primarily metabolized by CYP3A4 that prolong QT interval (e.g., pimozide, quinidine). Avoid use in patients with known serious cardiac arrhythmias, including ventricular tachycardia and torsades de pointes.
Possible side effect
Common adverse reactions (≥1%) include diarrhea/loose stools (5–10%), nausea (3–5%), abdominal pain (2–3%), vomiting (1–2%), and headache. Less frequently, dizziness, rash, elevated liver transaminases, and vaginitis may occur. Serious but rare side effects include hepatotoxicity, cholestatic jaundice, QT prolongation and subsequent torsades de pointes, hearing loss (usually reversible), and severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrocology). Clostridioides difficile-associated diarrhea, ranging from mild to life-threatening colitis, has been reported.
Drug interaction
Azithromycin has moderate CYP3A4 inhibitory properties and may increase concentrations of coadministered drugs metabolized by this pathway. Significant interactions include increased levels and toxicity of ergotamine, dihydroergotamine, colchicine (contraindicated in renal/hepatic impairment), and certain statins (monitor for rhabdomyolysis). Concurrent use with other QT-prolonging agents (e.g., fluoroquinolones, antipsychotics, antiarrhythmics) increases arrhythmia risk. Antacids containing aluminum or magnesium may reduce absorption; administer at least 2 hours apart. May potentiate warfarin effect (monitor INR). Nelfinavir significantly increases azithromycin levels; consider dose adjustment.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time of the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up. Inconsistent dosing may reduce efficacy and increase the risk of antibiotic resistance.
Overdose
Symptoms may include severe nausea, vomiting, diarrhea, and temporary hearing loss. Management is supportive; gastric lavage may be considered if ingestion was recent. There is no specific antidote. Hemodialysis is not effective due to high protein binding and extensive tissue distribution. Monitor ECG for QT prolongation and provide symptomatic care. Contact a poison control center for latest guidance.
Storage
Store tablets and powder for oral suspension at controlled room temperature (20–25°C or 68–77°F). Protect from light and moisture. Once reconstituted, the oral suspension is stable for 10 days at room temperature or refrigerated; do not freeze. Discard any unused portion after this period. Keep all medications out of reach of children and pets.
Disclaimer
This information is intended for healthcare professionals and is not a substitute for clinical judgment. Prescribing decisions must be based on the individual patient’s condition, susceptibility patterns, and current treatment guidelines. The prescriber should be familiar with the complete prescribing information and local resistance patterns. Dosage may need adjustment in special populations. Always report adverse events to the appropriate regulatory authority.
Reviews
“Zithromax remains a workhorse in outpatient infectious disease for its reliability and patient-friendly profile. The short course is a significant advantage in non-adherent populations.” – Infectious Disease Specialist, 12 years experience.
“I’ve used azithromycin extensively in pediatric practice. The once-daily dosing and generally good tolerability make it a preferred option for compliant ear and respiratory infections.” – Pediatrician, 8 years experience.
“While effective, clinicians must remain vigilant for cardiac and hepatic adverse effects, particularly in polymedicated elderly patients. Its role is well-established but requires prudent use.” – Clinical Pharmacologist, 15 years experience.